Cabazitaxel is a second line chemotherapy drug recently approved for the treatment of metastatic castration-resistant prostate cancer. A first panel of French experts and a second independent panel of
Definitions and measures of asthma control used in clinical trials and practice often vary, as highlighted in the manuscript, “Is asthma control more than just an absence of symptoms? An expert consen
